8-K/A

AMENDMENT NO. 1 TO CURRENT REPORT

Company: ABVC BIOPHARMA, INC.
Filed: November 28, 2017
Period of Report: November 20, 2017
Accession Number: 0001213900-17-012691

View Document ↗ View on SEC.gov ↗